Medical Journals

Inhibition of Cytosolic Phospholipase A2alpha: Hit to Lead Optimization.

Authors:
  • McKew John C
  • Foley Megan A
  • Thakker Paresh
  • Behnke Mark L
  • Lovering Frank E
  • Sum Fuk-Wah
  • Tam Steve
  • Wu Kun
  • Shen Marina W H
  • Zhang Wen
  • Gonzalez Mario
  • Liu Shanghao
  • Mahadevan Anu
  • Sard Howard
  • Khor Soo Peang
  • Clark James D

From: Department of Chemical and Screening Sciences, Wyeth Research, 200 CambridgePark Drive, Cambridge, Massachusetts 02140, USA. jmckew@wyeth.com

Journal of medicinal chemistry

  • Publish Date: Jan 2006
  • ISSN: 0022-2623
  • Volume: 49
  • Issue: 1
  • Pages: 135-58
  • Medium: Print
  • Language: English
  • Citation (JAMA): McKew John C, Foley Megan A, Thakker Paresh, et al. Inhibition of Cytosolic Phospholipase A2alpha: Hit to Lead Optimization.. J. Med. Chem. Jan 2006;49:135-58

Abstract

Compound 1 was previously reported to be a potent inhibitor of cPLA(2)alpha in both artificial monomeric substrate and cell-based assays. However, 1 was inactive in whole blood assays previously used to characterize cyclooxygenase and lipoxygenase inhibitors. The IC(50) of 1 increased dramatically with cell number or lipid/detergent concentration. In an attempt to insert an electrophilic ketone between the indole and benzoic acid moieties, we discovered that increasing the distance between the two moieties gave a compound with activity in the GLU (7-hydroxycoumarinyl-gamma-linolenate) micelle assay, which contains lipid and detergent. Extensive structure-activity relationship work around this lead identified a potent pharmacophore for cPLA(2)alpha inhibition. The IC(50)s between the GLU micelle and rat whole blood assays correlated highly. No correlation was found for other parameters, including lipophilicity or acidity of the required acid functionality. Compounds 25, 39, and 94 emerged as potent, selective inhibitors of cPLA(2)alpha and represent well-validated starting points for further optimization.

Mesh Headings (Keywords): Animals, Cell Line, Cell Proliferation, Cytosol, Drug Design, Drug Evaluation, Preclinical, Enzyme Inhibitors, Group IV Phospholipases A2, Humans, Indoles, Male, Molecular Structure, Phospholipases A, Rats, Rats, Sprague-Dawley, Structure-Activity Relationship


Check for Full Text / PubMed Unique Identifier (PMID): 16392799


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.